To evaluate the risk of neurodevelopmental disorders (NDDs) in children with prenatal exposure to azithromycin compared to those exposed to other antibiotics and those unexposed during gestation.
Key Findings:
The study found limited evidence linking prenatal azithromycin exposure to an increased risk of neurodevelopmental disorders in offspring, highlighting the inconclusiveness of the findings.
The risk of NDDs was assessed across different exposure periods during pregnancy.
Findings suggest that while azithromycin has potential adverse effects, its impact on neurodevelopmental outcomes remains uncertain.
Interpretation:
The results indicate that while azithromycin is widely used during pregnancy, its association with neurodevelopmental disorders in children requires further investigation, particularly regarding specific risk factors and mechanisms.
Limitations:
The study relies on administrative claims data, which may have limitations in accuracy and completeness.
Potential confounding factors may not have been fully accounted for in the analysis.
The observational nature of the study limits causal inferences, and there may be biases inherent in retrospective studies.
Conclusion:
Further research is needed to clarify the relationship between prenatal azithromycin exposure and neurodevelopmental outcomes, particularly given the critical nature of early pregnancy for cognitive development and its implications for clinical practice.
by Marianne N. Otoo, Kimford J. Meador, Todd Brothers, Thomas Lavoie, Nicole J. Asal, Brian J. Quilliam, Don Keon Yon, Carmen Monthe-Dreze, Kristina E. Ward, Jing Wu, Adam K. Lewkowitz, Xuerong Wen
The nurse practitioner profession claims the No. 1 spot across three categories in the U.S. News & World Report 2026 Best Jobs rankings for the third consecutive year.
